Evidence map›Paper›PMID 38525001›Full record

ArticleInterventional radiology (Higashimatsuyama-shi (Japan)2024

A Case of Life-threatening Rupture of Small Renal Angiomyolipoma with an Unidentified Intratumoral Aneurysm during Follow-up.

Masashi Tajiri, Tomoyuki Gentsu, Masato Yamaguchi, Koji Sasaki, Eisuke Ueshima, Takuya Okada, Koji Sugimoto, Takamichi Murakami

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Interventional radiology (Higashimatsuyama-shi (Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Masashi TajiriDepartment of Radiology, Osaka Police Hospital, Japan.
Tomoyuki GentsuDepartment of Radiology, Kobe University Graduate School of Medicine, Japan.
Masato YamaguchiDepartment of Radiology, Kobe University Graduate School of Medicine, Japan.
Koji SasakiDepartment of Radiology, Kobe University Graduate School of Medicine, Japan.
Eisuke UeshimaDepartment of Radiology, Kobe University Graduate School of Medicine, Japan.
Takuya OkadaDepartment of Radiology, Kobe University Graduate School of Medicine, Japan.
Koji SugimotoDepartment of Radiology, Kobe University Graduate School of Medicine, Japan.
Takamichi MurakamiDepartment of Radiology, Kobe University Graduate School of Medicine, Japan.
Kobe University · JPOsaka Police Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of a life-threatening ruptured renal angiomyolipoma (AML) that did not meet the criteria for prophylactic treatment (tumor >4 cm or intratumoral aneurysm >5 mm) during follow-up. A woman in her 70s was followed up for a 2.5-cm AML with a rich vascular component. An intratumoral aneurysm >5 mm was not identified for 2 years. She complained of a sudden abdominal pain with hypotension, and contrast-enhanced computed tomography revealed a retroperitoneal hematoma with contrast media extravasation from an intratumoral aneurysm. Emergency transcatheter arterial embolization was successfully performed using N-butyl cyanoacrylate glue. Rupture can occur in small AMLs or in AMLs not identified with intratumoral aneurysms during follow-up. AMLs with a rich vascular component at the kidney surface are more likely to rupture.

Indexed as

N-butyl cyanoacrylaterenal angiomyolipomaretroperitoneal hemorrhagetranscatheter arterial embolizationtreatment criteria

Identifiers

PMID38525001
PMCPMC10955477
OpenAlexW4391592907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.